<DOC>
	<DOCNO>NCT00248820</DOCNO>
	<brief_summary>This study intend assess ability contrast-enhanced ultrasound detection benign malignant ovarian mass compare unenhanced ultrasound . By use intravascular contrast agent , noninvasive feasible imaging technique allow investigator define specific microcirculation pattern 100 woman ovarian lesion . The intravascular contrast agent property compare benign malignant adnexal mass . The final purpose ultrasonography allow early detection tumor improve characterization benign malignant lesion .</brief_summary>
	<brief_title>Contrast-Enhanced Ultrasound Ability Characterization Ovarian Masses</brief_title>
	<detailed_description>SonoVue ( Sulphur hexafluoride microbubbles ) microbubbles preparation stable , resistant pressure specifically design use contrast agent ultrasound image . Study design : one contrast-enhanced ultrasonography propose surgery patient ovarian mass .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>18 year age old Patient adnexal mass detect ultrasound Any program surgery Any contraindication surgery Injection another contrast agent within 24 hour study examination Pregnancy , breastfeed Patient know coronary syndrome Unstable angina myocardial infarction Acute cardiac failure , Class III/IV cardiac failure Severe rhythm disorder Acute endocarditis Prosthetic valve Patient previously receive investigational drug within 30 day prior admission study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Contrast-enhanced Ultrasound</keyword>
	<keyword>Ultrasound Contrast agent , microbubbles</keyword>
	<keyword>Ovarian tumor</keyword>
	<keyword>vascularization</keyword>
</DOC>